๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Bevacizumab - Medicines in Ireland

11 authorised products containing Bevacizumab, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 11 authorised medicines
MedicineActive substanceLicence holderStatus
Abevmy 25 mg/mL concentrate for solution for infusion
EU/1/20/1515/001-005
Bevacizumab Biosimilar Collaborations Ireland Limited โ€”
Alymsys 25 mg/mL concentrate for solution for infusion
EU/1/20/1509/001-002
Bevacizumab Mabxience Research, S.L. โ€”
Avastin 25 mg/ml concentrate for solution for infusion
EU/1/04/300/001-002
Bevacizumab Roche Registration GmbH โ€”
Avastin 25 mg/ml Concentrate for solution for infusion
EU/1/04/300/1-2
Bevacizumab Roche Registration Limited โ€”
Aybintio 25 mg/ml concentrate for solution for infusion
EU/1/20/1454/001
Bevacizumab Samsung Bioepis NL B.V. โ€”
Aybintio 25 mg/ml concentrate for solution for infusion
EU/1/20/1454/002
Bevacizumab Samsung Bioepis NL B.V. โ€”
Lytenava 25 mg/mL solution for injection
EU/1/24/1798/001
Bevacizumab Outlook Therapeutics NL B.V. โ€”
MVASI 25 mg/mL Concentrate for solution for infusion
EU/1/17/1246/001-002
Bevacizumab Amgen Technology (Ireland) Unlimited Company โ€”
Oyavas 25 mg/mL concentrate for solution for infusion
EU/1/20/1510/001-002
Bevacizumab Stada Arzneimittel AG โ€”
Vegzelma 25 mg/mL concentrate for solution for infusion
EU/1/22/1667/001-004
Bevacizumab Celltrion Healthcare Hungary Kft. โ€”
Zirabev 25 mg/ml concentrate for solution for infusion
EU/1/18/1344/001-002
Bevacizumab Pfizer Europe MA EEIG โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.